109820 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. Its products include pharmaceutical products for respiratory, sexually transmitted, human papillomavirus, and gastrointestinal infections. The company was founded on December 7, 2000 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
109820 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company